| # | Drug | Count |
|---|---|---|
| 0 | ISOTRETINOIN | 75 |
| 1 | ADALIMUMAB | 62 |
| 2 | CAPECITABINE | 30 |
| 3 | BEVACIZUMAB | 23 |
| 4 | OXALIPLATIN | 22 |
| 5 | FLUOROURACIL | 20 |
| 6 | FLUOROURACIL CREAM, 0.5% | 20 |
| 7 | METRONIDAZOLE | 16 |
| 8 | OMEPRAZOLE MAGNESIUM | 16 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 2 | 0.0247 |
| 1 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 2 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| 3 | DEXCHLORPHENIRAMINE MALEATE | 2 | 0.0020 |
| 4 | ETOPOSIDE PHOSPHATE | 3 | 0.0018 |
| 5 | TAZAROTENE | 2 | 0.0017 |
| 6 | ISOTRETINOIN | 75 | 0.0015 |
| 7 | NELFINAVIR MESYLATE | 3 | 0.0014 |
| 8 | NIZATIDINE | 2 | 0.0013 |
| 9 | INOTUZUMAB OZOGAMICIN | 3 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 75 |
| 1 | Corticosteroid [EPC] | 53 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 53 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 4 | Platinum-based Drug [EPC] | 40 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 23 |
| 6 | Benzodiazepine [EPC] | 18 |
| 7 | Vitamin B12 [EPC] | 18 |
| 8 | Vitamin C [EPC] | 18 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Retinoid [EPC] | 75 | 0.0003 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 16 | 0.0002 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 53 | 0.0002 |
| 6 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 7 | Sulfone [EPC] | 2 | 0.0002 |
| 8 | Platinum-based Drug [EPC] | 40 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 13 | 0.0001 |